[Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
Ten chronic schizophrenics were tested by clinical observations, psychological tests (FPI, LEV, d 2) and ratings with the Wittenborn-Psychiatric-Ratings-Scales (WPRS) before and after taking 2-pyrrolidon-acetamid. The improvement of obstructive, apathy, withdrawal and affective flatness in seven patients justify a double-blind psychometric evaluation concerning the effect of Piracetam on the schizophrenic deficiency states.
D000328:Adult; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D008875:Middle Aged; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011594:Psychometrics; D011760:Pyrrolidinones / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
D011760:Pyrrolidinones; D010889:Piracetam
Klinische Prüfung von 2-Pyrrolidon-Acetamid (Generic Name: Piracetam)--Eine Pilot Study